万东医疗
(600055)
| 流通市值：121.63亿 | | | 总市值：121.63亿 |
| 流通股本：7.03亿 | | | 总股本：7.03亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,586,378,532.07 | 2,903,543,571.16 | 3,017,472,241.85 | 3,033,694,706.47 |
| 应收票据及应收账款 | 381,205,179.51 | 392,567,835.25 | 343,082,836.23 | 268,526,353.58 |
| 其中：应收票据 | - | 5,745,626 | 2,905,374.76 | - |
| 应收账款 | 381,205,179.51 | 386,822,209.25 | 340,177,461.47 | 268,526,353.58 |
| 应收款项融资 | 1,842,000 | - | - | - |
| 预付款项 | 12,516,367.21 | 65,276,550.8 | 66,970,076.32 | 51,215,244.55 |
| 其他应收款合计 | 26,312,734.88 | 47,291,334.26 | 41,580,228.09 | 34,220,309.7 |
| 存货 | 214,942,655.77 | 281,143,062.92 | 308,798,369.73 | 335,158,653.02 |
| 合同资产 | 2,121,505.65 | 1,405,953.4 | 1,405,953.4 | 1,146,182.4 |
| 一年内到期的非流动资产 | 208,600,702.65 | 236,567,034.52 | 241,022,254.54 | 202,314,489.36 |
| 其他流动资产 | 17,450,395.41 | 3,190,385.05 | 3,453,689.25 | 37,479,985.58 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 4,451,370,073.15 | 4,397,172,234.2 | 4,349,567,265.84 | 4,273,756,064.39 |
| 非流动资产: | | | | |
| 长期应收款 | 43,105,240.81 | 30,730,956.15 | 49,784,910.68 | 108,645,942.63 |
| 长期股权投资 | 14,844,686.82 | 15,124,102.47 | 16,289,054.47 | 16,428,676.79 |
| 其他非流动金融资产 | 341,778,344.15 | 344,776,878.98 | 344,776,878.98 | 344,776,878.98 |
| 投资性房地产 | 158,216,422.04 | 181,515,546.23 | 183,489,930.92 | 185,464,315.61 |
| 固定资产 | 225,967,770.34 | 168,005,617.92 | 171,195,848.64 | 173,319,957.79 |
| 在建工程 | 11,800,899.97 | 10,419,999.11 | 6,790,279.52 | 6,300,088.19 |
| 使用权资产 | 18,056,365.04 | 11,451,094.38 | 12,336,476 | 13,221,857.72 |
| 无形资产 | 26,771,032.81 | 23,895,824.49 | 10,266,980.97 | 11,954,516.46 |
| 开发支出 | 34,120,125.45 | 13,992,732.23 | 14,656,085.58 | 14,656,085.58 |
| 长期待摊费用 | 17,000,365.95 | 17,755,754.17 | 16,769,207.33 | 17,609,756.26 |
| 递延所得税资产 | 74,322,652.76 | 70,662,532.99 | 70,662,532.99 | 71,698,184.13 |
| 其他非流动资产 | 53,139,064 | 48,352,353.69 | 48,352,353.69 | 48,352,353.69 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,019,122,970.14 | 936,683,392.81 | 945,370,539.77 | 1,012,428,613.83 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,470,493,043.29 | 5,333,855,627.01 | 5,294,937,805.61 | 5,286,184,678.22 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 325,290,157.26 | 252,007,268.03 | 238,363,758.49 | 194,899,224.67 |
| 其中：应付票据 | 81,953,935.54 | 74,848,713.38 | 58,425,978.98 | 55,339,283.23 |
| 应付账款 | 243,336,221.72 | 177,158,554.65 | 179,937,779.51 | 139,559,941.44 |
| 预收款项 | 71,483.18 | - | - | - |
| 合同负债 | 76,803,721.47 | 74,088,835.24 | 82,229,322.66 | 101,523,888.42 |
| 应付职工薪酬 | 39,910,466.17 | 40,200,961.69 | 37,128,775.92 | 35,807,821.19 |
| 应交税费 | 31,158,912.75 | 25,115,403.86 | 19,591,153.36 | 2,835,114.18 |
| 其他应付款合计 | 37,300,370.88 | 27,398,463.84 | 29,678,450.37 | 21,223,220.08 |
| 一年内到期的非流动负债 | 6,506,013.35 | 2,487,315.06 | 4,006,882.05 | 4,345,942.06 |
| 其他流动负债 | 17,713,743.97 | 12,868,031.49 | 15,358,980.97 | 22,237,533.31 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 534,754,869.03 | 434,166,279.21 | 426,357,323.82 | 382,872,743.91 |
| 非流动负债: | | | | |
| 租赁负债 | 14,325,889.49 | 11,186,905.6 | 11,186,905.6 | 11,400,325.11 |
| 长期应付款 | 224,084.55 | 334,237.81 | 353,613.73 | 372,605.86 |
| 长期应付职工薪酬 | 19,263,000 | 17,946,000 | 17,946,000 | 17,946,000 |
| 预计负债 | 4,345,720.95 | - | - | - |
| 递延收益 | 19,590,418.94 | 20,546,989.47 | 20,546,989.47 | 18,625,322.8 |
| 递延所得税负债 | - | 169,828.63 | 169,828.63 | 169,828.63 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 57,749,113.93 | 50,183,961.51 | 50,203,337.43 | 48,514,082.4 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 592,503,982.96 | 484,350,240.72 | 476,560,661.25 | 431,386,826.31 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 703,061,058 | 703,061,058 | 703,061,058 | 703,061,058 |
| 其他权益工具 | - | 2,782,039,277.14 | - | - |
| 资本公积 | 2,770,450,049.55 | - | 2,782,039,277.14 | 2,778,387,089.01 |
| 其他综合收益 | -5,005,475 | -3,062,375 | -3,062,375 | -3,062,375 |
| 盈余公积 | 240,722,145.17 | 225,224,435.67 | 225,224,435.67 | 225,224,435.67 |
| 未分配利润 | 1,058,318,801.32 | 1,032,198,878.19 | 1,001,207,281.78 | 1,041,120,871.17 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,767,546,579.04 | 4,739,461,274 | 4,708,469,677.59 | 4,744,731,078.85 |
| 少数股东权益 | 110,442,481.29 | 110,044,112.29 | 109,907,466.77 | 110,066,773.06 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 4,877,989,060.33 | 4,849,505,386.29 | 4,818,377,144.36 | 4,854,797,851.91 |
| 负债和股东权益合计 | 5,470,493,043.29 | 5,333,855,627.01 | 5,294,937,805.61 | 5,286,184,678.22 |
| 公告日期 | 2025-03-22 | 2024-10-26 | 2024-08-17 | 2024-04-27 |
| 审计意见(境内) | 标准无保留意见 | | | |